These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22700010)

  • 21. Organometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death.
    Nazarov AA; Gardini D; Baquié M; Juillerat-Jeanneret L; Serkova TP; Shevtsova EP; Scopelliti R; Dyson PJ
    Dalton Trans; 2013 Feb; 42(7):2347-50. PubMed ID: 23223548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms.
    Vock CA; Ang WH; Scolaro C; Phillips AD; Lagopoulos L; Juillerat-Jeanneret L; Sava G; Scopelliti R; Dyson PJ
    J Med Chem; 2007 May; 50(9):2166-75. PubMed ID: 17419606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double targeting of tumours with pyrenyl-modified dendrimers encapsulated in an arene-ruthenium metallaprism.
    Pitto-Barry A; Barry NP; Zava O; Deschenaux R; Dyson PJ; Therrien B
    Chemistry; 2011 Feb; 17(6):1966-71. PubMed ID: 21274948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Light-activated ruthenium complexes photobind DNA and are cytotoxic in the photodynamic therapy window.
    Wachter E; Heidary DK; Howerton BS; Parkin S; Glazer EC
    Chem Commun (Camb); 2012 Oct; 48(77):9649-51. PubMed ID: 22908094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies.
    Li J; Guo L; Tian Z; Zhang S; Xu Z; Han Y; Li R; Li Y; Liu Z
    Inorg Chem; 2018 Nov; 57(21):13552-13563. PubMed ID: 30289251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
    Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
    Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-targeted organometallic ruthenium(II)-arene anticancer complexes bearing inhibitors of poly(ADP-ribose) polymerase-1: A strategy to improve cytotoxicity.
    Wang Z; Qian H; Yiu SM; Sun J; Zhu G
    J Inorg Biochem; 2014 Feb; 131():47-55. PubMed ID: 24239912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligonuclear polypyridylruthenium(II) complexes incorporating flexible polar and non-polar bridges: synthesis, DNA-binding and cytotoxicity.
    Mulyana Y; Weber DK; Buck DP; Motti CA; Collins JG; Keene FR
    Dalton Trans; 2011 Feb; 40(7):1510-23. PubMed ID: 21218244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective, cytotoxic organoruthenium(II) full-sandwich complexes: a structural, computational and in vitro biological study.
    Loughrey BT; Cunning BV; Healy PC; Brown CL; Parsons PG; Williams ML
    Chem Asian J; 2012 Jan; 7(1):112-21. PubMed ID: 22095971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, structural characterization, solution chemistry, and preliminary biological studies of the ruthenium(III) complexes [TzH][trans-RuCl4(Tz)2] and [TzH][trans-RuCl4(DMSO)(Tz)].(DMSO), the thiazole analogues of antitumor ICR and NAMI-A.
    Mura P; Camalli M; Messori L; Piccioli F; Zanello P; Corsini M
    Inorg Chem; 2004 Jun; 43(13):3863-70. PubMed ID: 15206867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ruthenium(II)-arene complexes with functionalized pyridines: synthesis, characterization and cytotoxic activity.
    Grgurić-Sipka S; Ivanović I; Rakić G; Todorović N; Gligorijević N; Radulović S; Arion VB; Keppler BK; Tesić ZLj
    Eur J Med Chem; 2010 Mar; 45(3):1051-8. PubMed ID: 20053483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and investigation of anticancer ruthenium-arene Schiff-base complexes via water-promoted combinatorial three-component assembly.
    Chow MJ; Licona C; Yuan Qiang Wong D; Pastorin G; Gaiddon C; Ang WH
    J Med Chem; 2014 Jul; 57(14):6043-59. PubMed ID: 25023617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, characterization, and in vitro evaluation of a potentially selective anticancer, mixed-metal [ruthenium(III)-platinum(II)] trinuclear complex.
    Herman A; Tanski JM; Tibbetts MF; Anderson CM
    Inorg Chem; 2008 Jan; 47(1):274-80. PubMed ID: 18062685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, characterization, antiproliferative and anti-metastatic properties of two ruthenium-DMSO complexes containing 2,2'-biimidazole.
    Tan C; Hu S; Liu J; Ji L
    Eur J Med Chem; 2011 May; 46(5):1555-63. PubMed ID: 21354673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction.
    Jadhav GR; Sinha S; Chhabra M; Paira P
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2695-700. PubMed ID: 27090558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ruthenium (II) polypyridyl complexes stabilize the bcl-2 promoter quadruplex and induce apoptosis of Hela tumor cells.
    Wang C; Yu Q; Yang L; Liu Y; Sun D; Huang Y; Zhou Y; Zhang Q; Liu J
    Biometals; 2013 Jun; 26(3):387-402. PubMed ID: 23543383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dinuclear Organoruthenium Complexes Exhibiting Antiproliferative Activity through DNA Damage and a Reactive-Oxygen-Species-Mediated Endoplasmic Reticulum Stress Pathway.
    Zhao J; Li S; Wang X; Xu G; Gou S
    Inorg Chem; 2019 Feb; 58(3):2208-2217. PubMed ID: 30675781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian cancer activity of cyclic amine and thiaether metal complexes.
    Medvetz DA; Stakleff KD; Schreiber T; Custer PD; Hindi K; Panzner MJ; Blanco DD; Taschner MJ; Tessier CA; Youngs WJ
    J Med Chem; 2007 Apr; 50(7):1703-6. PubMed ID: 17343369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maleimide-functionalised organoruthenium anticancer agents and their binding to thiol-containing biomolecules.
    Hanif M; Nazarov AA; Legin A; Groessl M; Arion VB; Jakupec MA; Tsybin YO; Dyson PJ; Keppler BK; Hartinger CG
    Chem Commun (Camb); 2012 Feb; 48(10):1475-7. PubMed ID: 22003496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.